FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014776263> ?p ?o ?g. }

• W2014776263 endingPage "782" @default.
• W2014776263 startingPage "775" @default.
• W2014776263 abstract "Background The Italian Society of Human Genetics' (SIGU) recommendations on genetic counseling and testing for hereditary melanoma state that clinical genetic testing can be offered to Italian melanoma families with at least two affected members. Objective In the framework of a cooperative study, we sought to establish the frequency of cyclin-dependent kinase inhibitor 2A mutations in melanoma families that underwent clinical genetic counseling and testing in accordance with the SIGU recommendations at 9 centers in different Italian regions. Methods Cyclin-dependent kinase inhibitor 2A testing was conducted by direct sequencing and multiplex ligation-dependent probe amplification analysis in melanoma families with at least two affected members. Results A total of 33% (68/204) of the families harbored cyclin-dependent kinase inhibitor 2A mutations. In the 145 families with two affected members the mutation frequency was 25%. Three novel mutations, L94P, A86T, and c.407dupG, were identified among the cases and not in 200 controls. Limitations We were unable to perform separate analyses for individual centers, as in some cases the number of families was too small. Conclusions The availability of clinical genetic testing for melanoma to families with just two affected members in the same branch is justified in Italy in terms of the likelihood of identifying a mutation. The Italian Society of Human Genetics' (SIGU) recommendations on genetic counseling and testing for hereditary melanoma state that clinical genetic testing can be offered to Italian melanoma families with at least two affected members. In the framework of a cooperative study, we sought to establish the frequency of cyclin-dependent kinase inhibitor 2A mutations in melanoma families that underwent clinical genetic counseling and testing in accordance with the SIGU recommendations at 9 centers in different Italian regions. Cyclin-dependent kinase inhibitor 2A testing was conducted by direct sequencing and multiplex ligation-dependent probe amplification analysis in melanoma families with at least two affected members. A total of 33% (68/204) of the families harbored cyclin-dependent kinase inhibitor 2A mutations. In the 145 families with two affected members the mutation frequency was 25%. Three novel mutations, L94P, A86T, and c.407dupG, were identified among the cases and not in 200 controls. We were unable to perform separate analyses for individual centers, as in some cases the number of families was too small. The availability of clinical genetic testing for melanoma to families with just two affected members in the same branch is justified in Italy in terms of the likelihood of identifying a mutation." @default.
• W2014776263 created "2016-06-24" @default.
• W2014776263 creator A5007431288 @default.
• W2014776263 creator A5011973671 @default.
• W2014776263 creator A5012928833 @default.
• W2014776263 creator A5021447572 @default.
• W2014776263 creator A5025473720 @default.
• W2014776263 creator A5029398339 @default.
• W2014776263 creator A5029528824 @default.
• W2014776263 creator A5032128128 @default.
• W2014776263 creator A5034950570 @default.
• W2014776263 creator A5035470784 @default.
• W2014776263 creator A5036052073 @default.
• W2014776263 creator A5036941849 @default.
• W2014776263 creator A5044458139 @default.
• W2014776263 creator A5047685403 @default.
• W2014776263 creator A5049759990 @default.
• W2014776263 creator A5051287878 @default.
• W2014776263 creator A5053034134 @default.
• W2014776263 creator A5057828080 @default.
• W2014776263 creator A5066544087 @default.
• W2014776263 creator A5068968117 @default.
• W2014776263 creator A5069078162 @default.
• W2014776263 creator A5071929183 @default.
• W2014776263 creator A5079922146 @default.
• W2014776263 creator A5082780385 @default.
• W2014776263 creator A5082792780 @default.
• W2014776263 creator A5088653335 @default.
• W2014776263 creator A5089552352 @default.
• W2014776263 date "2009-11-01" @default.
• W2014776263 modified "2023-10-18" @default.
• W2014776263 title "Clinical genetic testing for familial melanoma in Italy: A cooperative study" @default.
• W2014776263 cites W107843614 @default.
• W2014776263 cites W1946633045 @default.
• W2014776263 cites W1965304382 @default.
• W2014776263 cites W1973277018 @default.
• W2014776263 cites W1983554886 @default.
• W2014776263 cites W1994179705 @default.
• W2014776263 cites W1995973428 @default.
• W2014776263 cites W1996227395 @default.
• W2014776263 cites W2000292536 @default.
• W2014776263 cites W2003108314 @default.
• W2014776263 cites W2004984342 @default.
• W2014776263 cites W2009025520 @default.
• W2014776263 cites W2016964879 @default.
• W2014776263 cites W2024191665 @default.
• W2014776263 cites W2026376689 @default.
• W2014776263 cites W2027891814 @default.
• W2014776263 cites W2028621040 @default.
• W2014776263 cites W2040147138 @default.
• W2014776263 cites W2041458198 @default.
• W2014776263 cites W2051506850 @default.
• W2014776263 cites W2055324830 @default.
• W2014776263 cites W2064678081 @default.
• W2014776263 cites W2075067527 @default.
• W2014776263 cites W2087424590 @default.
• W2014776263 cites W2087791044 @default.
• W2014776263 cites W2096479012 @default.
• W2014776263 cites W2105576511 @default.
• W2014776263 cites W2109882425 @default.
• W2014776263 cites W2113496553 @default.
• W2014776263 cites W2115763961 @default.
• W2014776263 cites W2119634186 @default.
• W2014776263 cites W2145200245 @default.
• W2014776263 cites W2169493518 @default.
• W2014776263 cites W2403285751 @default.
• W2014776263 cites W4247623075 @default.
• W2014776263 doi "https://doi.org/10.1016/j.jaad.2009.03.039" @default.
• W2014776263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19500876" @default.
• W2014776263 hasPublicationYear "2009" @default.
• W2014776263 type Work @default.
• W2014776263 sameAs 2014776263 @default.
• W2014776263 citedByCount "42" @default.
• W2014776263 countsByYear W20147762632012 @default.
• W2014776263 countsByYear W20147762632013 @default.
• W2014776263 countsByYear W20147762632014 @default.
• W2014776263 countsByYear W20147762632015 @default.
• W2014776263 countsByYear W20147762632016 @default.
• W2014776263 countsByYear W20147762632017 @default.
• W2014776263 countsByYear W20147762632018 @default.
• W2014776263 countsByYear W20147762632019 @default.
• W2014776263 countsByYear W20147762632020 @default.
• W2014776263 countsByYear W20147762632021 @default.
• W2014776263 countsByYear W20147762632022 @default.
• W2014776263 countsByYear W20147762632023 @default.
• W2014776263 crossrefType "journal-article" @default.
• W2014776263 hasAuthorship W2014776263A5007431288 @default.
• W2014776263 hasAuthorship W2014776263A5011973671 @default.
• W2014776263 hasAuthorship W2014776263A5012928833 @default.
• W2014776263 hasAuthorship W2014776263A5021447572 @default.
• W2014776263 hasAuthorship W2014776263A5025473720 @default.
• W2014776263 hasAuthorship W2014776263A5029398339 @default.
• W2014776263 hasAuthorship W2014776263A5029528824 @default.
• W2014776263 hasAuthorship W2014776263A5032128128 @default.
• W2014776263 hasAuthorship W2014776263A5034950570 @default.
• W2014776263 hasAuthorship W2014776263A5035470784 @default.
• W2014776263 hasAuthorship W2014776263A5036052073 @default.
• W2014776263 hasAuthorship W2014776263A5036941849 @default.

• next